Company Filing History:
4 out of 1,343 
1 out of 49 Years Active: 2021-2025
Title: **Inventor Spotlight: Christopher Schoenherr**
Introduction
Christopher Schoenherr, a prominent inventor based in Piermont, NY, has made significant contributions to the field of biotechnology through his innovative research and development. With a portfolio of four patents, Schoenherr's work focuses on pioneering methods and compositions that address crucial challenges in enzyme-deficiency diseases and genetic modifications.
Latest Patents
Schoenherr's latest patents showcase his expertise in therapeutic proteins and genetic engineering. One notable patent introduces compositions and methods for internalizing enzymes, revealing innovative approaches for treating enzyme-deficiency diseases. This patent highlights multidomain therapeutic proteins that can efficiently enter cells, segregate to the lysosome, and deliver essential enzyme activity.
Another significant patent involves nucleic acids comprising a modified rodent activin A receptor type 1 (Acvr1) gene. This genetically modified rodent model presents groundbreaking potential for studying ectopic bone formation, using site-specific recombinase recognition sites to invert the altered gene upon recombinase action.
Career Highlights
Throughout his career, Schoenherr has collaborated with leading biotech firms, including Regeneron Pharmaceuticals, Inc. His work at Regeneron has been pivotal in advancing therapeutic solutions that address various health conditions requiring innovative enzyme replacement therapies.
Collaborations
Collaboration has played a vital role in Schoenherr's achievements, working alongside distinguished colleagues such as Katherine Cygnar and Christos Kyratsous. These partnerships have fostered a dynamic environment that promotes the exchange of ideas and expertise, further enhancing the impact of their collective research.
Conclusion
Christopher Schoenherr stands out as an influential inventor whose patents and research are paving the way for advancements in biotechnology. His dedication to solving pressing medical challenges through innovative solutions underscores the importance of continued research and collaboration in the field. As technologies grow and evolve, Schoenherr’s contributions will undoubtedly have a lasting impact on the future of therapeutic interventions.